We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

223 hedge funds and large institutions have $902M invested in Maravai LifeSciences in 2023 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 81 increasing their positions, 64 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 31

27% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 64

9% more funds holding

Funds holding: 204 → 223 (+19)

1.95% more ownership

Funds ownership: 102.27% → 104.22% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

33% less capital invested

Capital invested by funds: $1.35B → $902M (-$446M)

50% less call options, than puts

Call options by funds: $1.64M | Put options by funds: $3.28M

Holders
223
Holders Change
+19
Holders Change %
+9.31%
% of All Funds
3.25%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
55
Increased
81
Reduced
64
Closed
31
Calls
$1.64M
Puts
$3.28M
Net Calls
-$1.64M
Net Calls Change
-$2.98M

Top Buyers

Rank Fund Capital Flow
1
1WCM
12 West Capital Management
New York
+$33.2M
2
Morgan Stanley
Morgan Stanley
New York
+$27.9M
3
PE
Point72 Europe
United Kingdom
+$16.8M
4
Marshall Wace
Marshall Wace
United Kingdom
+$12.2M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$11.3M

Top Sellers

Rank Fund Capital Flow
1
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$74.5M
2
Jennison Associates
Jennison Associates
New York
-$25.5M
3
Holocene Advisors
Holocene Advisors
New York
-$21.5M
4
ClearBridge Investments
ClearBridge Investments
New York
-$14.9M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$13.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
26
Systematic Financial Management
New Jersey
$8.67M +$971K +150,234 +13%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$8.07M +$2.99M +463,246 +60%
Citadel Advisors
28
Citadel Advisors
Florida
$7.5M -$3.98M -616,448 -35%
GIP
29
Granite Investment Partners
California
$7.36M -$2.36M -364,669 -25%
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$6.23M +$6.15M +951,200 New
Northern Trust
31
Northern Trust
Illinois
$6.2M -$286K -44,222 -4%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$6.03M -$1.41M -217,881 -19%
Qube Research & Technologies (QRT)
33
Qube Research & Technologies (QRT)
United Kingdom
$5.28M +$5.21M +805,954 New
ClearBridge Investments
34
ClearBridge Investments
New York
$5.1M -$14.9M -2,300,571 -75%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$3.85M -$2.37M -366,597 -38%
Charles Schwab
36
Charles Schwab
California
$3.69M -$307K -47,512 -8%
Bank of America
37
Bank of America
North Carolina
$3.54M -$4.23M -654,087 -55%
GAM
38
Gotham Asset Management
New York
$3.44M +$5.81K +900 +0.2%
KCM
39
Kornitzer Capital Management
Kansas
$3.38M – – –
Balyasny Asset Management
40
Balyasny Asset Management
Illinois
$3.25M -$530K -82,061 -14%
Janus Henderson Group
41
Janus Henderson Group
United Kingdom
$3M -$275K -42,595 -9%
Fidelity Investments
42
Fidelity Investments
Massachusetts
$2.99M +$2.91M +450,379 +6,595%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$2.68M -$687K -106,331 -21%
APC
44
Alpine Peaks Capital
New York
$2.65M +$295K +45,600 +13%
Voloridge Investment Management
45
Voloridge Investment Management
Florida
$2.57M +$2.54M +392,492 New
SOADOR
46
State of Alaska Department of Revenue
Alaska
$2.56M – – –
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$2.47M +$367K +56,834 +18%
JP Morgan Chase
48
JP Morgan Chase
New York
$2.46M +$361K +55,828 +17%
MAM
49
Monaco Asset Management
Monaco
$2.04M +$2.01M +311,210 New
Squarepoint
50
Squarepoint
New York
$2.03M +$2M +310,020 New
1
2
3 4 5

MRVI Hedge Fund Activity: Q4 2023 in Review

223 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q4 2023, worth a combined $902M — down 33% from $1.35B a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new MRVI positions and 31 closed out — a net gain of 24 holders — while 81 added to existing stakes and 64 trimmed.

The largest buyer was 12 West Capital Management, adding an estimated $33.2M. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $74.5M.

  • 223 institutional investors held Maravai LifeSciences (MRVI) as of Q4 2023, up from 204 in Q3 2023.
  • Funds reported $902M of Maravai LifeSciences stock for Q4 2023, down 33% quarter-over-quarter.
  • 55 funds opened new Maravai LifeSciences positions in Q4 2023 and 31 closed out, a net change of +24 holders.
  • The largest Maravai LifeSciences buyer in Q4 2023 was 12 West Capital Management, an estimated $33.2M added.
  • The largest Maravai LifeSciences seller in Q4 2023 was Thrivent Financial for Lutherans, an estimated $74.5M sold.

Based on aggregated 13F filings for Q4 2023.